| Mass screening of asymptomatic persons for severe acute respiratory syndrome coronavirus 2 using saliva I Yokota, PY Shane, K Okada, Y Unoki, Y Yang, T Inao, K Sakamaki, ... Clinical Infectious Diseases 73 (3), e559-e565, 2021 | 195 | 2021 |
| Equivalent SARS-CoV-2 viral loads by PCR between nasopharyngeal swab and saliva in symptomatic patients I Yokota, T Hattori, PY Shane, S Konno, A Nagasaka, K Takeyabu, ... Scientific reports 11 (1), 4500, 2021 | 39 | 2021 |
| Successful treatment of eosinophilic granulomatosis with polyangiitis (EGPA; formerly Churg–Strauss syndrome) with rituximab in a case refractory to glucocorticoids … N Umezawa, H Kohsaka, T Nanki, K Watanabe, M Tanaka, PY Shane, ... Modern Rheumatology 24 (4), 685-687, 2014 | 31 | 2014 |
| A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study I Yokota, PY Shane, K Okada, Y Unoki, Y Yang, S Iwasaki, S Fujisawa, ... The Lancet Microbe 2 (8), e397-e404, 2021 | 30 | 2021 |
| Logistic advantage of two-step screening strategy for SARS-CoV-2 at airport quarantine I Yokota, PY Shane, T Teshima Travel medicine and infectious disease 43, 102127, 2021 | 20 | 2021 |
| Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study): A multicentre, double-blind, randomized, placebo … Y Fujieda, T Horita, N Nishimoto, K Tanimura, Y Amasaki, H Kasahara, ... Modern Rheumatology 31 (3), 593-599, 2021 | 16 | 2021 |
| Medical education during the COVID-19: a review of guidelines and policies adapted during the 2020 pandemic S Saeki, R Okada, PY Shane Healthcare 11 (6), 867, 2023 | 8 | 2023 |
| Equivalent SARS-CoV-2 viral loads by PCR between nasopharyngeal swab and saliva in symptomatic patients. Sci Rep 11: 4500 I Yokota, T Hattori, PY Shane, S Konno, A Nagasaka, K Takeyabu, ... | 6 | 2021 |
| A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study. Lancet Microbe 2021; 2: e397–404 I Yokota, PY Shane, K Okada, Y Unoki, Y Yang, S Iwasaki | 5 | |
| IgG4-related sialoadenitis with a skin lesion and multiple mononeuropathies suggesting coexistent cryoglobulinemic vasculitis M Kamiya, PY Shane, M Soejima, S Tohda, N Miyasaka, H Kohsaka Internal Medicine 55 (10), 1355-1361, 2016 | 4 | 2016 |
| A novel strategy for sars-cov-2 mass-screening using quantitative antigen testing of saliva I Yokota, PY Shane, K Okada, Y Unoki, Y Yang, S Iwasaki, S Fujisawa, ... | 2 | 2020 |
| Reply to Iwata and Yoshimura, and Endo I Yokota, K Sakamaki, PY Shane, T Teshima Clinical Infectious Diseases 73 (11), e3986-e3987, 2021 | | 2021 |
| Logistic Advantage of Two-Step Screening Strategy for SARS-CoV-2 T Teshima, I Yokota, PY Shane SSRN Electronic Journal, 2021 | | 2021 |
| Logistic Advantage of Two-Step Screening Strategy for SARS-CoV-2 I Yokota, PY Shane, T Teshima Available at SSRN 3771476, 2021 | | 2021 |
| Novel TNFα inhibitor, certolizumab pegol PY Shane, S Onodera Drug Delivery System 29 (2), 160-165, 2014 | | 2014 |
| Clinical features of patients with anti-neutrophil cytoplasmic autoantibodies targeting native myeloperoxidase antigen Y Yamanishi, T Ito-Ihara, T Nagao, K Uno, S Kobayashi, E Muso, ... Modern rheumatology 23 (5), 963-971, 2013 | | 2013 |
